rx 821002 has been researched along with methyldopa in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (methyldopa) | Trials (methyldopa) | Recent Studies (post-2010) (methyldopa) |
---|---|---|---|---|---|
317 | 0 | 45 | 3,719 | 420 | 143 |
Protein | Taxonomy | rx 821002 (IC50) | methyldopa (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 5.228 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.176 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.126 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Head, GA; Sannajust, F | 1 |
1 other study(ies) available for rx 821002 and methyldopa
Article | Year |
---|---|
Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; Dioxanes; Dose-Response Relationship, Drug; Female; Heart Rate; Hypotension; Idazoxan; Imidazoline Receptors; Male; Methyldopa; Oxazoles; Rabbits; Receptors, Drug; Rilmenidine | 1994 |